-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A666745 | Anti-cMet & EGFR Reference Antibody (Amivantamab), Target:cMet&EGFR,Uniprot:P08581&P00533,Species:Human,isotype:IgG-like Anti-cMet & EGFR Reference Antibody (Amivantamab), Target:cMet&EGFR,Uniprot:P08581&P00533,Species:Human,isotype:IgG-like |
|||
| A666761 | Anti-cMet & EGFR Reference Antibody (Emb01), Target:cMet&EGFR,Uniprot:P08581&P00533,Species:Human,isotype:Fab-IgG Anti-cMet & EGFR Reference Antibody (Emb01), Target:cMet&EGFR,Uniprot:P08581&P00533,Species:Human,isotype:Fab-IgG |
|||
| A666762 | Anti-cMet Reference Antibody (Davutamig), Target:cMet,Uniprot:P08581,Species:Human,isotype:IgG-like Anti-cMet Reference Antibody (Davutamig), Target:cMet,Uniprot:P08581,Species:Human,isotype:IgG-like |
|||
| A998560 | Anti-Complement C2 Reference Antibody (ARGX-117), Anti-Complement C2 Reference Antibody (ARGX-117), |
|||
| A998561 | Anti-Complement C3 Reference Antibody (NGM621), Anti-Complement C3 Reference Antibody (NGM621), |
|||
| A998562 | Anti-Complement C5 Reference Antibody (crovalimab), Anti-Complement C5 Reference Antibody (crovalimab), |
|||
| A998563 | Anti-Complement C5 Reference Antibody (eculizumab), Anti-Complement C5 Reference Antibody (eculizumab), |
|||
| A998564 | Anti-Complement C5 Reference Antibody (lendalizumab), Anti-Complement C5 Reference Antibody (lendalizumab), |
|||
| A998565 | Anti-Complement C5 Reference Antibody (pozelimab), Anti-Complement C5 Reference Antibody (pozelimab), |
|||
| A998566 | Anti-Complement C5 Reference Antibody (ravulizumab), Anti-Complement C5 Reference Antibody (ravulizumab), |
|||
| A998567 | Anti-Complement C5 Reference Antibody (tesidolumab), Anti-Complement C5 Reference Antibody (tesidolumab), |
|||
| A998568 | Anti-Complement C5 Reference Antibody (vilobelimab), Anti-Complement C5 Reference Antibody (vilobelimab), |
|||
| A998569 | Anti-Complement C5aR1 Reference Antibody (avdoralimab), Anti-Complement C5aR1 Reference Antibody (avdoralimab), |
|||
| A998570 | Anti-Complement C5aR1 Reference Antibody (G2 patent anti-C5aR), Anti-Complement C5aR1 Reference Antibody (G2 patent anti-C5aR), |
|||
| A998571 | Anti-Complement C5aR1 Reference Antibody (G2_anti-C5aR), Anti-Complement C5aR1 Reference Antibody (G2_anti-C5aR), |
|||
| A998572 | Anti-Complement Factor B Reference Antibody (Genentech patent anti-Factor B), Anti-Complement Factor B Reference Antibody (Genentech patent anti-Factor B), |
|||
| A998573 | Anti-Complement Factor D Reference Antibody (lampalizumab), Anti-Complement Factor D Reference Antibody (lampalizumab), |
|||
| A998574 | Anti-Complement Factor P / Properdin Reference Antibody (Novelmed patent anti-Properdin), Anti-Complement Factor P / Properdin Reference Antibody (Novelmed patent anti-Properdin), |
|||
| A998576 | Anti-CRTAM / CD355 Reference Antibody (Oxford Bio patent anti-CRTAM), Anti-CRTAM / CD355 Reference Antibody (Oxford Bio patent anti-CRTAM), |
|||
| A998577 | Anti-CSF1 / M-CSF Reference Antibody (lacnotuzumab), Anti-CSF1 / M-CSF Reference Antibody (lacnotuzumab), |
